Centers for Disease Control, Department of Health, Taiwan, ROC.
J Microbiol Immunol Infect. 2012 Apr;45(2):79-89. doi: 10.1016/j.jmii.2012.03.007. Epub 2012 Apr 5.
Multi-drug-resistant organisms are increasingly recognized as a global public health issue. Healthcare-associated infection and antimicrobial resistance are also current challenges to the treatment of infectious diseases in Taiwan. Government health policies and the health care systems play a crucial role in determining the efficacy of interventions to contain antimicrobial resistance. National commitment to understand and address the problem is prerequisite. We analyzed and reviewed the antibiotic resistance related policies in Taiwan, USA, WHO and draft antimicrobial stewardship program to control effectively antibiotic resistance and spreading in Taiwan. Antimicrobial stewardship program in Taiwan includes establishment of national inter-sectoral antimicrobial stewardship task force, implementing antimicrobial-resistance management strategies, surveillance of HAI and antimicrobial resistance, conducting hospital infection control, enforcement of appropriate regulations and audit of antimicrobial use through hospital accreditation, inspection and national health insurance payment system. No action today, no cure tomorrow. Taiwan CDC would take a multifaceted, evidence-based approach and make every effort to combat antimicrobial resistance with stakeholders to limit the spread of multi-drug resistant strains and to reduce the generation of antibiotic resistant bacteria in Taiwan.
多药耐药菌越来越被认为是一个全球公共卫生问题。医疗保健相关感染和抗菌素耐药性也是台湾治疗传染病的当前挑战。政府卫生政策和医疗保健系统在确定控制抗菌素耐药性的干预措施的效果方面发挥着关键作用。国家对问题的理解和解决的承诺是前提。我们分析和审查了台湾、美国、世界卫生组织的抗菌素耐药性相关政策以及控制抗菌素耐药性和传播的抗菌素管理计划草案。台湾的抗菌素管理计划包括建立国家跨部门抗菌素管理工作组、实施抗菌素耐药性管理策略、监测医院获得性感染和抗菌素耐药性、进行医院感染控制、通过医院认证、检查和国家健康保险支付系统执行适当的法规和抗菌素使用审核。今天不采取行动,明天就无药可救。台湾疾病管制署将与利益攸关方采取多方面、循证的方法,努力对抗抗菌素耐药性,以限制多药耐药菌株的传播,并减少台湾抗生素耐药细菌的产生。